Lung neoplasms Flashcards
(36 cards)
What is a hamartoma?
It is a disorganized admixture of cells indiginous to that site. Includes, blood vessels, glands, cartilage, smooth muscle, inflammatory cells, fat, etc in various proportions
Radiographically, what is a hamartoma of the lung called?
Coin lesion
Describe a lung hamartoma macroscopically
It is a well-circumscribed spherical small mass (1-4cm). It is a discrete lesion with yellowish pale cut surface. Often has calcifications recognizable on radiography.
What is a choristoma?
It is a mass composed of normal tissues but in an ectopic location. EG pancreatic islets in liver or stomach.
Usually what causes a hamartoma?
It is caused by clonal expansion of cells with 6p21 or 12q14
q15 chromosomal alterations
What is the differential diagnoses for hamartoma?
The differential diagnosis includes granuloma,
small primary carcinoma, solitary metastasis, or
hamartoma
Microscopically, what does a pulmonary hamartoma look like?
cartilage that is jumbled with a fibrovascular stroma and scattered bronchial
glandular structures
T/F Most lung tumors are benign. Explain
F they are malignant
metastatic tumors are the most common lung carcinoma seen in clinical
practice
What is Atypical adenomatous hyperplasia (AAH)?
It is a small (<5mm) lesion characterised by dysplastic pneumocytes lining alveolar wall that are midly fibrotic
What is adenocarcinoma in situ (AIS)?
A lesion 3cm or less composed of cells that are entirely dysplastic, growing along peexisting alveolar septa without rapturing it. Has a lepidic growth pattern
when the AIS becomes invasive, it forms what?
It forms desmoplasia (fibrosis)
What is a minimally invasive adenocarcinoma (MIA)?
<3cm lesion. It is a solitary adenocarcinoma with either pure lepidic growth or predominant lepidic growth with <5cm of stromal invasion
List the 3 precursor lesions associated with adenocarcinoma
- Atypical adenomatous hyperplasia (AAH)
- Adenocarcinoma in situ (AIS)
- Minimally invasive adenocarcinoma (MIA)
What is a bronchoalveolar carcinoma?
It is a subtype of adenocarcinoma. But this type does not have any stromal, vascular, or pleural invasion. The tumor grows along thr pre-existing alveolar septa
Broncheoalveolar carcinoma has which type of spread?
It has an aerogenous spread. It does not have metastatic spread
What is the common cause of death for bronchoalveolar carcinoma?
Due to involvement of the airways,
the patient usually dies by suffocation
What are the clinical features of bronchoalveolar carcinoma? (7)
Cough
Weight loss
Dyspnoea
Anorexia
Fatigue
Hemoptysis
Chest pain
Describe the metastatic pattern of bronchoalveolar carcinoma
Metastasis of the cancer causes involvement of adrenal (most commonly) followed by liver, brain and bone.
Intrathoracic spread of the cancer causes enlargement of lymph nodes (hilar, mediastinal, bronchial and
tracheal), pleural involvement,
hoarseness (recurrent laryngeal nerve invasion),
dysphagia (esophageal obstruction),
diaphragmatic paralysis (phrenic nerve paralysis),
Horner syndrome and
superior vena cava (SVC) syndrome
List 5 endocrinological syndromes associated with bronchogenic cancer, and their causes
a. Cushing syndrome (Due to ACTH)
b. Syndrome of inappropriate ADH secretion (SIADH) [Due to anti-diuretic hormone]
c. Hypercalcemia: Due to parathyroid hormone related peptide (PTH related peptide).
d. Hypocalcemia: Due to calcitonin
e. Gynecomastia: Due to gonadotropins
Which paraneoplastic syndrome is caused by autoantibodies against neuronal calcium channel?
Lambert eaton syndrome
Which paraneoplastic syndrome is causes hyperpigmentation of the axillary region?
Acanthosis nigrans
Explain the pathogenesis of bronchogenic cancer
1.Stepwise accumulation Oncogenic driver mutations causes neoplastic transformation of epithelial cells
What are the subdivisions of bronchogenic cancer?
Commonly divided into non-small cell (including adenocarcinoma, squamous cell carcinoma, other types) and small cell
carcinoma based on behaviour and prognosis.
Pathogenesis of adenocarcinoma
Most common type in never-smokers, although it is also associated to a lesser extent with smoking. A third
of adenocarcinomas have oncogenic gain-of-function mutations involving growth factor receptor signalling pathways that can
be targeted by specific inhibitors e.g. tyrosine kinase receptors (EGFR, ALK, ROS1) or their downstream molecules (KRAS –
usually in smokers)